Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Patient communication AI company receives $65M in funding from private equity
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.
Interventional cardiology groups unite to push the specialty forward
SCAI and CRT have announced a new partnership focused on education, advocacy and research.
3-in-1 TAVR guidewire linked to faster procedures, less radiation
The sensor-guided device delivers continuous hemodynamic measurements and rapid left ventricular pacing during TAVR procedures. Back in 2023, it was at the heart of a $253 million acquisition.
Stem cell company acquires 2 cardiology practices, calling them ‘the first of many’
Hemostemix believes its new cell therapy platform can help treat peripheral artery disease, congestive heart failure, cardiomyopathy and other serious medical conditions. The company plans on scooping up multiple practices to conduct additional research and increase the use of its platform.
FDA announces Class I recall of patches used for heart surgery
There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.

Medtronic TAVR valves at heart of multiple sessions during New York cardiology conference

Medtronic’s TAVR technology received a significant amount of attention during the very first New York Valves conference in New York City. Research focused on patients with small annuli as well as how five-year outcomes compare to surgery.

Jagmeet Singh, MD, PhD, Professor of Medicine, Harvard Medical School, and Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program at Mass General Hospital, delivered a key note address at HRS 2024 on the future of artificial intelligence in EP and AI applications in cardiology. #HRS #EPeeps #HRS2024 #HRS24 #HealthAI

Embracing AI to enhance EP: Insights from cardiologist Jagmeet Singh

Jagmeet Singh, MD, delivered a keynote address at HRS 2024 on the future of AI in electrophysiology. He spoke to Cardiovascular Business, sharing additional thoughts about the topic.

FDA panel recommends new COVID-19 booster

Booster uptake rates remain low. To date, only 22.5% of Americans received an annual COVID-19 shot from 2023.

Edwards shares new data highlighting consistency of its TAVR valves in women, patients with small annuli

Researchers explored five-year data from more than 1,300 TAVR patients treated with a balloon-expandable Sapien 3 valve, sharing their findings at New York Valves 2024: The Structural Heart Summit.

Another common artificial sweetener linked to higher risk of heart attack, stroke

According to new research led by Cleveland Clinic cardiologists, consuming high levels of xylitol can significantly increase a person's three-year risk of experiencing a major adverse cardiac event.

Mediterranean diet helps women live longer, reducing heart disease and cancer risks

Researchers explored decades of data from more than 25,000 women, sharing their findings in JAMA Network Open.

doctor examines patient data on their tablet

Engineers team with cardiologist to rethink heart pump assessments

The group’s work is focused on how signal processing technologies and machine learning can track the health of VADs and the patients who need them.

$Eko Health, the California-based healthcare technology company known for its advanced stethoscopes, has received U.S. Food and Drug Administration (FDA) approval for a new artificial intelligence (AI) offering designed to detect low ejection fraction (EF).$

Eko Health raises $41M to expand footprint of its AI-powered stethoscopes

Now that the company has gained FDA approval for multiple algorithms, Eko Health aims to reach as many patients as possible with its AI-powered devices.

Clinical

Patient communication AI company receives $65M in funding from private equity

Interventional cardiology groups unite to push the specialty forward

3-in-1 TAVR guidewire linked to faster procedures, less radiation

Stem cell company acquires 2 cardiology practices, calling them ‘the first of many’

FDA announces Class I recall of patches used for heart surgery